标题化合物

摘要： 本发明涉及一种制备高纯度约99%的式(I)吲哚菁绿的改进工艺,其包括1,1,2-三甲基-1H-苯并[e]吲哚与1,4-丁烷砜在沸腾溶剂中反应得到4-(1,1,2-三甲基-1H-苯并[e]吲哚-3-基)丁烷-1-磺酸的步骤。然后在醋酸钠和乙醇存在下,使式(IV)的4-(1,1,2-三甲基-1H-苯并[e]吲哚-3-基)丁烷-1-磺酸和式(V)的N-苯基-N-((1E,3E,5E)-5-(苯基亚胺)五-1,3-二烯基)乙酰胺反应;并用酯溶剂萃取标题化合物式(I)。

摘要： A novel fluorene derivative containing triphenylamine groups, 2,7-bis[4-(diphe- nylamino)-phenyl]fluorene (C49H36N2, Mr = 652.80), was synthesized via Suzuki coupling reaction (yield: 19%) and its crystal structure was determined by single-crystal X-ray diffraction. It crystallizes in triclinic, space group P1 with a = 9.320(4), b = 11.250(6), c = 17.369(6) A, a = 88.035(3), β = 86.450(5), γ = 73.524(5)°. V= 1742.8(13)A3, Z = 2, Dc = 1.244 g/cm3, p(MoKa) = 0.072 mm-1, F(000) = 688, S = 1.095, the final R = 0.0616 and wR = 0.1878. It presents a linear framework constituted by a linkage of fluorene as a bridge and two triphenylamine groups. Its spectral and electrochemical properties were studied by UV-Vis absorption, fluorescence spectroscopy and cyclic voltammetry (CV). This compound can emit intense blue fluorescence with a peak wavelength of 446 nm and a full width at half maximum (FWHM) of 38 nm under UV excitation at 350 nm in film. The highest occupied molecular orbital (HOMO) energy level, the lowest unoccupied molecular orbital (LUMO) energy level and optical band gap (Eg) of the title compound are -5.46, -2.57 and 2.89 eV, respectively.

摘要： A novel organic-inorganic hybrid, Na2(Hmorph)2[MosO26]·2H2O (1, Hmorph = morpholine), has been synthesized by convenient aqueous solution method and structurally characterized by single-crystal X-ray diffraction, IR, UV/Vis spectrum, elemental analysis and thermogravimetric analysis (TGA). Single-crystal X-ray analysis reveals that the title compound crystallizes in the monoclinic system, space group P21/c with a = 8.0194(4), b = 16.1398(8), c = 12.5893(6) A, fl = 92.824(4)°, V = 1627.47(14) A3, Mr = 1439.78, Z = 2, Dc = 2.938 g/cm3, p = 3.116 mm-1, F(000) = 1364, the final R = 0.0250, wR = 0.0628 and S = 1.027 for 3209 observed reflections with I 〉 2σ(/). In compound 1, the polyanions are stacked through electrostatic interactions, coordination of Na+ ions and hydrogen bonds to form a novel 3-D extended supramolecular "host" network with 1-D channels encapsulating organic "guests".

摘要： The title compound, 5-(1H-benzoimidazol-2-yl)-3H-[1,2,3]triazole-4-carboxylic acid (CIoH.7Ns.O2.C3H7NO, M,..= 302.30), has been synthesized and characterized by FT-IR and ES1-MS, ~H-NMR spectroscopy and X-ray single-crystal diffraction. Crystal structure of the title compound was grown from DMF by slow diffusion at room temperature. Crystal data: orthorhombic structure, space group Pna2+ with a = 6.9635(3), b = 19.4398(7), c = 30.6165(12) A, V = 4144.5(3) A3, Z = 12, Dc = 1.454 g/cm3,/l(MoKa) = 0.108 mm-1, and F(000) = 1896. The structure was refined to R = 0.0450 and wR = 0.0975 for 3578 observed reflections with 1 〉 2σ(I). The interm01ecular hydrogen bonds and π-π stacking further stabilize the structure.

摘要： The Pt(IV) complex cis,cis,trans-[Pt(PMSA)2Cl2(OH)2]·2H2O(1), where PMSA = N-3-pyridinylmethanesulfonamide, has been synthesized and characterized by elemental analysis, molar electric conductivity and IR spectrum. X-ray crystallography revealed that the title compound crystallizes in the monoclinic C2/c space group with unit cell dimensions a = 16.5424(7), b = 8.6973(3), c = 16.6079(6) A, β = 117.185(5)° and Z = 4. Pt(IV) has an octahedral coordination geometry and the PMSA ligands are coordinated via the pyridine N atom. They are in a transoid orientation between each other and are inclined in the same direction with respect to the Pt-C1-Cli-N-Ni plane at an angle of 64.6(1)° (symmetry operation: (i) 1- x, y, 3/2-z). The structure is stabilized by a system of hydrogen bonds involving the complex and water molecules.

摘要： The title compound of 2-nitro-9,9-bis(methylpropionate)fluorine (C21H21NO6, Mr = 383.39) was synthesized for the first time. Complete assignments were achieved by 1H NMR, IR, EI-MS, elemental analysis and single-crystal X-ray diffraction technique. The crystal belongs to monoclinic, space group P21/c with a = 11.4581(15), b = 10.3624(14), c = 16.573(2) A.,/? = 96.629(2)°, V = 1954.6(5) A3, Z = 4, Dc = 1.303 g/cm3, p = 0.096 mm-1, F(000) = 808, R = 0.0493 and wR = 0.1499 for 3107 observed reflections with I 〉 2tr(/). X-ray analysis reveals that three fused rings of the fluorene system are almost coplanar and the two ester groups are nearly perpendicular to the fused-ring system. Weak C-H...O hydrogen bonding connects the molecules into centrosymmetric dimmers.

摘要： The title compound has been synthesized by the reaction of 1-bromo-3,3-dime- thyl- 1 - (1 H- 1,2,4-triazol- 1 -yl)butan-2-one with 1 -(2-fluorophenyl)thiourea, and its crystal struc- ture was determined by single-crystal X-ray diffraction. The crystal belongs to the orthorhombic system, space group Pbca with a = 15.2568(6), b = 12.1533(5), c = 16.7307(7) A, Z = 8, V = 3102.2(2) A3, Mr = 317.39, Dc = 1.359 g/cm3, S = 1.05, μ = 0.223 mm-1, F(000) = 1328, the final R = 0.034 and wR = 0.097 for 2590 observed reflections (I 〉 2σ(I)). X-ray crystal structure presents the intramolecular N-H…N hydrogen bond, which plays an important role in stabilizing the crystal structure. In addition, the preliminary biological test on the title compound shows good antitumor activity, with IC50 of 0.122 μmol/mL against the Hela cell line.

摘要： A two-dimensional lead complex, [Pb(C14N3O2H12S)(NO3)]n·nH2O, was prepared by the reaction of salicylyl-4-phenyl thiosemicarbazide and lead nitrate. The compound (C14H13N4O6PbS, Mr = 572.53) crystallizes in the monoclinic space group P21/c with a = 11.2984(2), b = 15.6628(7), c = 11.1118(2)A,β= 113.564(2)°, V = 1802.43(10)A3, Dc= 2.110 g/cm3, Z = 4,μt(MoKα) = 9.515 mm-1, F(000) = 1084, the final R = 0.0394 and wR = 0.0701 for 2552 observed reflections with I 〉 2σ(I). The Pb(Ⅱ) ion displays a distorted octahedron in which the hypothesized stereochemically active lone pair occupies the apex. The compound exhibits a two-dimensional network structure formed by the zigzag one-dimensional chains joined by two μ-O of two nitrate groups in overlapping. A large ring exists in the two-dimensional layers. The TGA of the title compound has been studied.

摘要： The title compound of pedunculoside (C36H58O10), a main active triterpenoid saponin of Ilicis Rotundae Cortex, was isolated from the dried bark of Ilex rotunda Thunb., and characterized by X-ray diffraction analysis. It crystallizes in the orthorhombic system, space group P212121 with C36H58O10, a = 13.046(3), b = 21.038(4), c = 28.413(6) A, V = 7798.28(3) A3, Z = 8, Dc= 1.109 g/cm3, Mr = 650.82, F(000) = 2832, andμ = 0.080 mm-1. The final R = 0.0765 and wR = 0.1736 for 15117 observed reflections (I 〉 2σ(I)). The molecular crystal structure of pedunculoside shows relative stereochemistry of 3β, 19α,23-trihydroxy-urs- 12-en-28-oic acid-28-O-β-D-glucopy- rainosyl ester. The molecule is composed of one glucopyranosyl ring and five six-membered rings with ring junctures of A/B trans, B/C trans, and D/E cis. There are two C36H50O10 molecules in an asymmetric unit, and the title compound is stacked into a 2D layer structure through hydrogen bonds.

摘要： 目的:合成N-(顺式-4-异丙基环己基-1-甲酰基)-D苯丙氨酸和N-(反式-4-异丙基环己基-1-甲酰)-L苯丙氨酸. 方法:以4-异丙基环己烷甲酸为原料,在二环已基碳二亚胺(DCC)作用下,与N-羟基琥珀酰亚胺反应得到4-异丙基环己烷甲酸琥珀酰亚胺酯,柱层析分离得到顺式和反式异构体.顺式体与D-苯丙氨酸甲酯发生酰化反应,碱水解后即得到N-(顺式-4-异丙基环己基-1-甲酰)-D苯丙氨酸;而反式体与L-苯丙氨酸甲酯发生酰化反应,水解后得到N-(反式-4-异丙基环己基-1-甲酰)-L苯丙氨酸. 结果与讨论:成功合成标题化合物,反应总收率分别为39﹪和31﹪.

摘要： 有效作为亲代谢性谷氨酸受体4亚类(mGluR4)变构增效剂/阳性别构调节物的吡唑并吡啶化合物、吡唑并吡嗪化合物、吡唑并吡嘧啶化合物、吡唑并噻吩化合物和吡唑并噻唑化合物；制造该化合物的合成方法；包括该化合物的药物组合物；和这些化合物的使用方法，例如，在治疗神经病学上的疾病和精神错乱或者其他与谷氨酸功能障碍有关的疾病状态方面的应用。

摘要： 在得到硫属化合物的膜状结晶时，有形成由Cu、In、Ga构成的金属膜并进行S e化处理的方法，但该方法中膜的均匀性和生产率存在问题。利用以低成本得到含有Cu-In-Ga-Se的纳米颗粒的方法，可以得到均匀性高的硫属化合物的膜状结晶，但硫属化合物中所含的碳量多，因此电阻值高，在太阳能电池用途等中无法得到令人满意的特性。通过将平均一次粒径为0.3μm以下的金属氢氧化物粉末和选自硒、硒化合物的组中的1种以上物质在还原性气体中加热到220°C以上，可以得到含有Cu-In-(Ga-)Se、且平均粒径(D50)低于0.5μm、粉末中的碳量为0.2质量%以下的硫属化合物粉。

摘要： 式(1)或(4)表示的β-二氢呋喃衍生化合物或β-四氢呋喃衍生化合物的制造方法、以及基于糖基化和脱保护的4’-乙炔基-2’,3’-双脱氢-3’-脱氧胸苷或类似化合物的制造方法，其特征在于，使式(2)或(3)表示的二元醇化合物与二碳酸二烷基酯、二碳酸二芳烷基酯或卤化物作用。

摘要： 提供使用通过加热引发的化学反应和扩散制造化合物半导体和化合物绝缘体的方法，使用该方法形成的化合物半导体和化合物绝缘体，以及包括该化合物半导体或化合物绝缘体的光电池、电子电路、晶体管和存储器。制造化合物半导体或化合物绝缘体的该方法包括：形成叠层结构，其包括置于含氧和/或硫的电介质层之间的对氧和/或硫是高度活性的稀土过渡金属中间层；以及加热该叠层结构，从而在电介质层与中间层之间引发化学反应和扩散，其中为了化合物半导体和化合物绝缘体，在不同温度下进行该加热。

摘要： 有效作为亲代谢性谷氨酸受体4亚类(mGluR4)变构增效剂/阳性别构调节物的吡唑并吡啶化合物、吡唑并吡嗪化合物、吡唑并吡嘧啶化合物、吡唑并噻吩化合物和吡唑并噻唑化合物；制造该化合物的合成方法；包括该化合物的药物组合物；和这些化合物的使用方法，例如，在治疗神经病学上的疾病和精神错乱或者其他与谷氨酸功能障碍有关的疾病状态方面的应用。

摘要： 本发明的化合物具有作为荧光发色团的下述通式1所示的三氮杂并环戊二烯骨架。

摘要： 在得到硫属化合物的膜状结晶时，有形成由Cu、In、Ga构成的金属膜并进行S e化处理的方法，但该方法中膜的均匀性和生产率存在问题。利用以低成本得到含有Cu-In-Ga-Se的纳米颗粒的方法，可以得到均匀性高的硫属化合物的膜状结晶，但硫属化合物中所含的碳量多，因此电阻值高，在太阳能电池用途等中无法得到令人满意的特性。通过将平均一次粒径为0.3μm以下的金属氢氧化物粉末和选自硒、硒化合物的组中的1种以上物质在还原性气体中加热到220°C以上，可以得到含有Cu-In-(Ga-)Se、且平均粒径(D50)低于0.5μm、粉末中的碳量为0.2质量%以下的硫属化合物粉。

摘要： 本发明涉及具有稳定作用，特别是对于有机材料的氧化、热和/或光化降解或破坏提供稳定作用的新型化合物。这些化合物表示为下面指定的通式I。本发明还涉及制备这种化合物的方法，涉及含有所述化合物的组合物，涉及通过所述稳定化化合物使有机化合物稳定的方法，并且涉及所述稳定化化合物使有机材料稳定的用途。

摘要： 本发明描述了作为式(I)芳烷基苄基醚类的抗真菌化合物：，其中：Ar代表芳基、咪唑基、1，2，4-三唑基、苯并咪唑基；R1、R2、R4和R5独立地为氢、卤素、C1-6烷基；R3代表卤素、C1-6烷基或O-R′，其中R′代表氢或低级烷基；R6代表芳基、取代芳基、三氟甲基、三氯甲基或O-R′，其中R′代表氢或低级烷基；芳基的取代基是卤素或四唑基；n和m独立地代表0与5之间的整数；条件是当Ar是咪唑基时，R3是氯，R6是p-苯基，且R1、R2、R4和R5是氢，n必须不同于2。当n和m不同于0和1时，R3或R6可以由并不必然相同的取代基代表。本发明也涉及它们的盐、溶剂化物、前药、酯、对映异构体和/或药学上可接受的非对映异构体，或其混合物，用于制备这些化合物的方法，中间体化合物，包含此类化合物和/或衍生物(包括这些化合物和/或衍生物)的药物组合物，以及这些化合物和/或衍生物用于治疗和/或预防由微生物(例如真菌、细菌和/或原生动物)引起的病况和/或疾病、用于抑制所述微生物的增殖和/或存活、用于治疗和/或预防微生物在个体中移殖和用于制造药物的用途和方法。

摘要： 本发明涉及的是具有治癌活性的新的喹啉类化合物(更准确讲是吲哚并喹啉类化合物)和新的吖啶类化合物(更准确讲是苯并(6)吖啶类化合物和苯并(e)吖啶类化合物)。本发明还涉及制备上述化合物的方法和含有该化合物的治癌组合物。